Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

yahoo.com - Usman Kabir - Crinetics Pharmaceuticals (CRNX): Billionaire Tom Steyer Likes This Pharma Stock
Crinetics Pharmaceuticals (CRNX): Billionaire Tom Steyer Likes This Pharma Stock
Yahoo!

We just covered Billionaire Tom Steyer's 10 Stock Picks with Huge Upside Potential and Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) ranks 6th on this list. Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) first appeared in the 13F portfolio of…

yahoo.com - Usman Kabir - Liquidia Corporation (LQDA): Billionaire Tom Steyer Admires This Pharma Stock
Liquidia Corporation (LQDA): Billionaire Tom Steyer Admires This Pharma Stock
Yahoo!

We just covered Billionaire Tom Steyer's 10 Stock Picks with Huge Upside Potential and Liquidia Corporation (NASDAQ:LQDA) ranks 1st on this list. Liquidia Corporation (NASDAQ:LQDA) first appeared in the 13F portfolio of Farallon Capital in the…

yahoo.com - Usman Kabir - BridgeBio Pharma Inc. (BBIO): Billionaire Tom Steyer Admires Upside Potential of This Stock
BridgeBio Pharma Inc. (BBIO): Billionaire Tom Steyer Admires Upside Potential of This Stock
Yahoo!

We just covered Billionaire Tom Steyer's 10 Stock Picks with Huge Upside Potential and BridgeBio Pharma, Inc. (NASDAQ:BBIO) ranks 2nd on this list. BridgeBio Pharma, Inc. (NASDAQ:BBIO) is a relatively recent addition to the 13F portfolio of…

marketbeat.com - Royalty Pharma PLC $RPRX Holdings Lifted by CM Management LLC
Royalty Pharma PLC $RPRX Holdings Lifted by CM Management LLC
MarketBeat

CM Management LLC grew its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 50.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 75,000 shares of the…

marketbeat.com - PFA Pension Forsikringsaktieselskab Acquires New Holdings in Royalty Pharma PLC $RPRX
PFA Pension Forsikringsaktieselskab Acquires New Holdings in Royalty Pharma PLC $RPRX
MarketBeat

PFA Pension Forsikringsaktieselskab purchased a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund…

thehindubusinessline.com - Aushadhi Express reefer rake launched to boost pharma cold-chain logistics
Aushadhi Express reefer rake launched to boost pharma cold-chain logistics
BusinessLine

An inaugural refrigerated container (Reefer) rake, Aushadhi Express, operated by Container Corporation of India (Concor), was flagged off from the Inland Container Depot (ICD) here to Jawaharlal Nehru Port Mumbai, carrying life-saving medicines and…

marketbeat.com - Hussman Strategic Advisors Inc. Buys New Stake in Royalty Pharma PLC $RPRX
Hussman Strategic Advisors Inc. Buys New Stake in Royalty Pharma PLC $RPRX
MarketBeat

Hussman Strategic Advisors Inc. acquired a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The fund acquired 63,000 shares of the…

rediff.com - Text Feed - Drug Trafficker Dola's Chemist Links Under Investigation
Drug Trafficker Dola's Chemist Links Under Investigation
Rediff.com

Investigators are uncovering the network of Mohammad Salim Dola, an international drug trafficker, focusing on his connections with chemists and pharma dealers who allegedly facilitated his illicit operations. Mohammad Salim Dola, an alleged…

timesleader.com - CAPITOL ROUNDUP: Lt. Gov. Davis highlights investments in 177 youth safety project grants
CAPITOL ROUNDUP: Lt. Gov. Davis highlights investments in 177 youth safety project grants
Times Leader

WILKES-BARRE — Lt. Governor Austin Davis this week highlighted the Shapiro-Davis Administration's continued investments in Pennsylvania's Violence Intervention and Prevention (VIP) and Building Opportunities through Out-of-School Time…

wsj.com - Peter Loftus - The Quest to Use AI to Help Find New Drugs
The Quest to Use AI to Help Find New Drugs
Wall Street Journal

Chief Executive Dave Ricks was on stage with founder Jensen Huang earlier this year in San Francisco touting the company's tech prowess when Huang teased him about the painstaking process of developing new drugs. “I'm really hoping that your…

cnbc.com - Leonie Kidd - Global week ahead: Is 'Sell in May' just a myth?
Global week ahead: Is 'Sell in May' just a myth?
CNBC

May trading gets underway following a record-breaking April for certain stock markets. Deutsche Bank looks to bust the myth of the 'sell in May' adage. Earnings season in Europe and Asia is still in full swing. Global central banks sound the alarm…

thehindu.com - Pti - NCB probes Dola's links with chemists, his Turkiye citizenship plans
NCB probes Dola's links with chemists, his Turkiye citizenship plans
The Hindu

Investigators probing the network of M ohammad Salim Dola, the alleged international drug trafficker brought back from Turkiye recently, have found his links with certain chemists and pharma dealers who were “aiding” the illicit…

indianexpress.com - Express News Service - Suspicious medicines worth over Rs 1.21 cr seized: Gujarat Health minister
Suspicious medicines worth over Rs 1.21 cr seized: Gujarat Health minister
The Indian Express

IN A series of raids by the Gujarat Food and Drugs Control Administration (FDCA), suspicious medicines worth over Rs 1.21 crore were seized this week, Health Minister Praful Pansheriya said on Saturday. Authorities have raided pharmaceutical firms…

thehindubusinessline.com - Movers & Shakers: Stocks That Will See Action This Week
Movers & Shakers: Stocks That Will See Action This Week
BusinessLine

Ajanta Pharma (₹2,824.60) The stock of Ajanta Pharma has been consolidating between ₹2,720 and ₹2,930 in the past month. But the trend has been up since October last year. Notably, post the breakout of ₹2,800, we had…

marketbeat.com - Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Receives Average Rating of 'Moderate Buy' from Brokerages
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Receives Average Rating of 'Moderate Buy' from Brokerages
MarketBeat

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Get Free Report) has been assigned an average rating of 'Moderate Buy' from the ten research firms that are currently covering the company, Marketbeat reports. One equities research analyst has rated…

Receive a Daily briefing on Pharma Industry News

Get Started